1. Home
  2. CGTX vs CENN Comparison

CGTX vs CENN Comparison

Compare CGTX & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • CENN
  • Stock Information
  • Founded
  • CGTX 2007
  • CENN 2013
  • Country
  • CGTX United States
  • CENN United States
  • Employees
  • CGTX N/A
  • CENN N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • CGTX Health Care
  • CENN Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • CENN Nasdaq
  • Market Cap
  • CGTX 20.5M
  • CENN 23.1M
  • IPO Year
  • CGTX 2021
  • CENN N/A
  • Fundamental
  • Price
  • CGTX $0.32
  • CENN $0.86
  • Analyst Decision
  • CGTX Strong Buy
  • CENN
  • Analyst Count
  • CGTX 5
  • CENN 0
  • Target Price
  • CGTX $5.63
  • CENN N/A
  • AVG Volume (30 Days)
  • CGTX 1.7M
  • CENN 134.9K
  • Earning Date
  • CGTX 05-07-2025
  • CENN 05-16-2025
  • Dividend Yield
  • CGTX N/A
  • CENN N/A
  • EPS Growth
  • CGTX N/A
  • CENN N/A
  • EPS
  • CGTX N/A
  • CENN N/A
  • Revenue
  • CGTX N/A
  • CENN $31,097,533.00
  • Revenue This Year
  • CGTX N/A
  • CENN N/A
  • Revenue Next Year
  • CGTX N/A
  • CENN N/A
  • P/E Ratio
  • CGTX N/A
  • CENN N/A
  • Revenue Growth
  • CGTX N/A
  • CENN 234.45
  • 52 Week Low
  • CGTX $0.22
  • CENN $0.64
  • 52 Week High
  • CGTX $2.54
  • CENN $1.95
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 47.90
  • CENN 45.15
  • Support Level
  • CGTX $0.24
  • CENN $0.84
  • Resistance Level
  • CGTX $0.34
  • CENN $0.94
  • Average True Range (ATR)
  • CGTX 0.03
  • CENN 0.07
  • MACD
  • CGTX -0.00
  • CENN -0.02
  • Stochastic Oscillator
  • CGTX 68.84
  • CENN 11.37

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: